Novel coronavirus mitigation measures implemented by radiotherapy centres in low and middle-income countries: a systematic review.
COVID-19
cancer
implementation
low and middle-income countries
radiotherapy
Journal
Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology
ISSN: 1507-1367
Titre abrégé: Rep Pract Oncol Radiother
Pays: Poland
ID NLM: 100885761
Informations de publication
Date de publication:
2021
2021
Historique:
received:
18
08
2020
accepted:
02
02
2021
entrez:
2
7
2021
pubmed:
3
7
2021
medline:
3
7
2021
Statut:
epublish
Résumé
The aim of the study was to identify strategies adopted by radiotherapy centres in low- and middle-income countries (LMICs) to mitigate the effects of COVID-19. Studies summarising COVID-19 mitigation strategies designed and implemented by radiotherapy centres in LMICs to avoid delays, deferrments and interruptions of radiotherapy services are lacking. A systematic review was conducted and reported in accordance with the preferred reporting items for systematic review and meta-analysis guideline. Ovid Embase, Ovid MEDLINE and CINAHL were searched for peer-reviewed articles that reported measures adopted by radiotherapy centres in LMICs to reduce the risk of COVID-19. Information on different strategies were extracted from the included studies and textual narrative synthesis was conducted. Of 60 articles retrieved, eleven were included. Majority of the studies were conducted in China. Ten of the included studies employed a qualitative design. Four themes were identified: preparing and equipping staff; reinforcing infection prevention and control policies; strengthening coordination and communication; and maintaining physical distancing. Studies reported that radiotherapy centres had: formed COVID-19 response multidisciplinary team; maximised the use of telehealth; adjusted the layout of waiting areas; divided staff into teams; dedicated a room for isolating suspected cases; and adopted triage systems. Local adaptation of established global strategies coupled with timely development of guidelines, flexibility and innovation have allowed radiotherapy leaders to continue to deliver radiotherapy services to cancer patients in LMICs during the COVID-19 crisis. Robust data collection must be encouraged in LMICs to provide an evidence-based knowledge for use in the event of another pandemic.
Sections du résumé
BACKGROUND
BACKGROUND
The aim of the study was to identify strategies adopted by radiotherapy centres in low- and middle-income countries (LMICs) to mitigate the effects of COVID-19. Studies summarising COVID-19 mitigation strategies designed and implemented by radiotherapy centres in LMICs to avoid delays, deferrments and interruptions of radiotherapy services are lacking.
MATERIALS AND METHODS
METHODS
A systematic review was conducted and reported in accordance with the preferred reporting items for systematic review and meta-analysis guideline. Ovid Embase, Ovid MEDLINE and CINAHL were searched for peer-reviewed articles that reported measures adopted by radiotherapy centres in LMICs to reduce the risk of COVID-19. Information on different strategies were extracted from the included studies and textual narrative synthesis was conducted.
RESULTS
RESULTS
Of 60 articles retrieved, eleven were included. Majority of the studies were conducted in China. Ten of the included studies employed a qualitative design. Four themes were identified: preparing and equipping staff; reinforcing infection prevention and control policies; strengthening coordination and communication; and maintaining physical distancing. Studies reported that radiotherapy centres had: formed COVID-19 response multidisciplinary team; maximised the use of telehealth; adjusted the layout of waiting areas; divided staff into teams; dedicated a room for isolating suspected cases; and adopted triage systems.
CONCLUSIONS
CONCLUSIONS
Local adaptation of established global strategies coupled with timely development of guidelines, flexibility and innovation have allowed radiotherapy leaders to continue to deliver radiotherapy services to cancer patients in LMICs during the COVID-19 crisis. Robust data collection must be encouraged in LMICs to provide an evidence-based knowledge for use in the event of another pandemic.
Identifiants
pubmed: 34211781
doi: 10.5603/RPOR.a2021.0032
pii: rpor-26-2-303
pmc: PMC8241298
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
303-315Informations de copyright
© 2021 Greater Poland Cancer Centre.
Déclaration de conflit d'intérêts
Conflict of interests The authors declare that they have no competing interest.
Références
JAMA. 2020 Apr 28;323(16):1549-1550
pubmed: 32176764
JAMA. 2020 Jun 2;323(21):2137-2138
pubmed: 32239184
Lancet Haematol. 2020 Jun;7(6):e432-e435
pubmed: 32339482
J Med Radiat Sci. 2020 Sep;67(3):243-248
pubmed: 32567800
N Engl J Med. 2020 Apr 30;382(18):e41
pubmed: 32212516
Radiother Oncol. 2020 Sep;150:191-194
pubmed: 32621832
Radiat Oncol J. 2020 Jun;38(2):93-98
pubmed: 33012152
Adv Radiat Oncol. 2020 Apr 14;5(4):550-557
pubmed: 32363247
Matern Child Health J. 2020 Sep;24(9):1104-1110
pubmed: 32564248
Adv Radiat Oncol. 2020 Mar 27;5(4):531-533
pubmed: 32775770
Sci Total Environ. 2020 Jul 10;725:138532
pubmed: 32304970
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Clinics (Sao Paulo). 2020 Jun 22;75:e2060
pubmed: 32578829
Arch Iran Med. 2020 Apr 01;23(4):255-264
pubmed: 32271599
Radiother Oncol. 2020 May;146:223-229
pubmed: 32342863
Radiother Oncol. 2020 Jul;148:203-210
pubmed: 32342870
Lancet Oncol. 2020 Apr;21(4):e181
pubmed: 32142621
Radiother Oncol. 2020 Aug;149:70-71
pubmed: 32387545
BMC Med Res Methodol. 2007 Jan 15;7:4
pubmed: 17224044
Cancer. 2020 Sep 15;126(18):4235-4245
pubmed: 32648950
Brachytherapy. 2020 Jul - Aug;19(4):412-414
pubmed: 32410912
Lancet. 2020 Mar 21;395(10228):922
pubmed: 32199474
Lancet Oncol. 2020 May;21(5):621-622
pubmed: 32251623
Infect Dis Poverty. 2020 Feb 28;9(1):24
pubmed: 32111262
In Vivo. 2020 Jun;34(3 Suppl):1675-1680
pubmed: 32503828
BMC Public Health. 2020 Aug 1;20(1):1193
pubmed: 32738884
Eur J Cancer. 2020 Aug;135:130-146
pubmed: 32580130
Ecancermedicalscience. 2020 May 28;14:1051
pubmed: 32565904
Radiother Oncol. 2020 Oct;151:314-321
pubmed: 32730830
Clin Transl Radiat Oncol. 2020 Mar 24;22:55-68
pubmed: 32274425